In Segment A, members will acquire distinct doses and schedules of oral ABBV-744 tablet to detect Protected dosing routine. Additional individuals are going to be enrolled on the determined monotherapy dosign program. In Phase B, members will get oral ruxolitinib and ABBV-744 will be presented as "increase-on" therapy. In Phase https://abbv-744therapeuticpotent46790.activoblog.com/33686369/5-essential-elements-for-abbv-744-drug-development-progress-and-timeline